Author information
1 Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Ronald Reagan Medical Center at UCLA, 757 Westwood Plaza, Suite 2125, Los Angeles, CA 90095, USA.
2 Division of Interventional Radiology, Department of Radiology, UCLA Medical Center, David Geffen School of Medicine at UCLA, Ronald Reagan Medical Center at UCLA, 757 Westwood Plaza, Suite 2125, Los Angeles, CA 90095, USA; Department of Surgery, Division of Liver and Pancreas Transplant Surgery, Ronald Reagan Medical Center at UCLA, 757 Westwood Plaza, Los Angeles, CA 90095, USA. Electronic address: edwardlee@mednet.ucla.edu.
Abstract
Transjugular intrahepatic portosystemic shunt (TIPS) is a well-established procedure used in the management of complications of portal hypertension. Although the most robust evidence supports the use of TIPS as salvage therapy in variceal hemorrhage, secondary prophylaxis of variceal bleeding, and treatment of refractory ascites, there is also data to suggest its efficacy in other indications such as hepatic hydrothorax, hepatorenal syndrome, and Budd-Chiari syndrome. Recent literature also suggests that TIPS may improve survival for certain subpopulations if placed early after variceal bleeding. This article provides an updated evidence-based review of the indications for TIPS. Outcomes, complications, and adequate patient selection are also discussed.